Testing effectiveness (Phase 2)WithdrawnNCT04841538
What this trial is testing
ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors
Who this might be right for
Thoracic TumorsNon-small Cell Lung CancerSmall Cell Lung Cancer
Elpiscience Biopharma, Ltd.